The Israeli Ministry of Health cleared commercial sales of the Pure-Vu system just weeks after Motus GI gained CE mark approval. The Israeli medical device market is one of the largest in the Middle East.
The Pure-Vu System is an FDA-approved bowel cleansing solution designed to improve visualization during colonoscopies.
“Given the large unmet need associated with insufficient bowel prep that exists throughout the world, we plan on continuing to assess potential partners who may be able to assist in scaling and accelerating our commercial footprint,” Motus GI CEO Tim Moran said in a press release.
More articles on surgery centers:
ASCs could get financial relief under $2 trillion stimulus law — 4 things to know
Can ASCs help with the COVID-19 surge?
California’s 750+ ASCs prepare to expand services for COVID-19 surge
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
